Biodyne Co., Ltd. (314930) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Biodyne Co., Ltd. (314930:KRX), powered by AI.

Current Price
₩10,400
P/E Ratio
363.5
Market Cap
309.5B
Sector
Healthcare
What is the Biodyne Co., Ltd. stock price forecast?

Biodyne Co., Ltd. is currently trading at ₩10,400. View real-time AI analysis on Alpha Lenz.

What is Biodyne Co., Ltd. insider trading activity?

View the latest insider trading data for Biodyne Co., Ltd. on Alpha Lenz.

What is Biodyne Co., Ltd.'s P/E ratio?

Biodyne Co., Ltd.'s P/E ratio is 363.5.

Biodyne Co., Ltd.

KRX · 314930
₩10,400+420(+4.21%)Market closedKRX regular session 09:00–15:30 KST
Ask about Biodyne Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Biodyne Co., Ltd. trades at a P/E of 363.5 (premium valuation) with modest ROE of 2.0%.

Ask for details

Company Overview

Biodyne Co., Ltd., a biotechnology company, is dedicated to pioneering advancements in the field of life sciences. Its primary function revolves around the development and commercialization of innovative therapeutic products and diagnostic solutions, aimed at addressing various medical challenges. With a strong focus on research and development, Biodyne Co., Ltd. works on the forefront of genetic and molecular research, contributing significantly to the pharmaceutical and healthcare industries. The company's extensive product portfolio encompasses novel biologics, specialized diagnostics, and personalized medicine solutions tailored to improve patient outcomes. Operating globally, Biodyne Co., Ltd. plays a crucial role in enhancing healthcare delivery through cutting-edge technology and scientific excellence. Its collaborations with academic institutions, hospitals, and industry partners underscore its commitment to driving progress in medical science. As a key player in the biotech sector, Biodyne Co., Ltd. supports a wide array of scientific research initiatives, reinforcing its position as a leader in innovation and efficiency in medical biotechnology.

CEO임욱빈
SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

₩309,546,671,200Market Cap
₩7,027,675,920Revenue
29.76MShares Out
0Employees

Margins

63.57%Gross
29.33%EBITDA
9.28%Operating
11.83%Pre-Tax
12.12%Net

Valuation

363.49P/E
7.02P/B
44.05EV/Sales
143.88EV/EBITDA
-64.40P/FCF

Growth (CAGR)

-16.82%Rev 3Yr
13.87%Rev 5Yr
-53.96%Op Inc 3Yr
N/AOp Inc 5Yr
-46.66%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

1.91%ROA
1.95%ROE
1.86%ROIC

Financial Health

₩12,980,772,310Cash & Cash Equivalents
₩-12,110,094,670Net Debt
1.98%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Biodyne Co., Ltd. (ticker: 314930) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). Market cap is $309.5B.

The current price is ₩10,400 with a P/E ratio of 363.49x and P/B of 7.02x.

ROE is 1.95% and operating margin is 9.28%. Annual revenue is $7.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Biodyne Co., Ltd. (314930) Stock Forecast 2026 ₩10,400 — Price, Financials & Analyst Targets | Alpha Lenz